Frovatriptan: A Viewpoint by Dr Hans Christoph Diener

ISSN： 1172-7047

Source： CNS Drugs, Vol.15, Iss.12, 2001-01, pp. : 977-978

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frovatriptan

By Easthope S.E. Goa K.L.

CNS Drugs, Vol. 15, Iss. 12, 2001-01 ,pp. : 969-976

Adis International

Access to resources Recommend Favorite

Ethinylestradiol/Chlormadinone Acetate: A Viewpoint by Hans Peter Zahradnik

By Zahradnik H.P.

Drugs, Vol. 64, Iss. 7, 2004-01 ,pp. : 761-762

Adis International

Access to resources Recommend Favorite

Memantine: A Viewpoint by Hans Förstl

By Förstl H.

Drugs & Aging, Vol. 20, Iss. 6, 2003-01 ,pp. : 477-478

Adis International

Access to resources Recommend Favorite

Pregabalin in the Treatment of Generalised Anxiety Disorder: A Viewpoint by Hans-Ulrich Wittchen

By Wittchen Hans-Ulrich

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 694-695

Adis International

Access to resources Recommend Favorite

Sumatriptan Fast-Disintegrating/Rapid-Release Tablets: A Viewpoint by Hans A. Carpay

By Carpay Hans A.

Drugs, Vol. 66, Iss. 6, 2006-01 ,pp. : 891-892

Adis International

Access to resources Recommend Favorite